Treatment of lentigo maligna

Cutis

Volumn 67, Issue 5, 2001, Pages 389-392

  Carucci, John A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMOSURGERY; HUMAN; LASER SURGERY; MALIGNANT LENTIGO; SKIN TUMOR;

HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; LASER SURGERY; MOHS SURGERY; SKIN NEOPLASMS;

EID: 0035348936     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1995;33:923-936.
2. Albert LS, Fewkes J, Sober AJ. Metastatic lentigo maligna melanoma. J Dermatol Surg Oncol. 1990;16:56-58.
3. Ringborg U, Afzelius LE, Lagerlof B, et al. Cutaneous malignant melanoma of the head and neck: analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer. 1993;71:751-758.
4. Cohen LM, McCall MW, Hodge SJ, et al. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections. Cancer. 1994;73:2964-2970.
5. Kuflik EG, Gage AA. Cryosurgery for lentigo maligna. J Am Acad Dermatol. 1994;31:75-78.
6. Arndt KA. Argon laser treatment of lentigo maligna. J Am Acad Dermatol. 1984;10:953-957.
7. Orten SS, Waner M, Dinehart SM, et al. Q-switched neodymium:yttrium-aluminum-garnet laser treatment of lentigo maligna. Otolaryngol Head Neck Surg. 1999;120: 296-302.
8. Thissen M, Westerhof W. Lentigo maligna treated with ruby laser [letter]. Acta Derm Venereol. 1997;77:163.
9. Schmid-Wendtner MH, Brunner B, Konz B, et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J Am Acad Dermatol. 2000; 43:477-482.
10. Tsang RW, Liu FF, Wells W, et al. Lentigo maligna of the head and neck: results of treatment by radiotherapy. Arch Dermatol. 1994;130:1008-1012.
11. Carucci JA, Leffell DJ. Intralesional interferon for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis. Arch Dermatol. 2000:136: 1415-1416.
12. Ryan RF, Krementz ET, Litwin MS. A role for topical 5-fluorouracil therapy in melanoma. J Surg Oncol. 1988;38: 250-256.
13. Rodriguez Prieto MA, Manchado Lopez P, Ruiz Gonzalez I, et al. Treatment of lentigo maligna with azelaic acid. Int J Dermatol. 1993;32:363-364.
14. Alper JC, Bogaars H, Sober AJ, et al. The surgical management of "in situ" melanoma. J Dermatol Surg Oncol. 1982;8:771-773.
15. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol. 1994;31:79-85.
16. Clayton BD, Leshin B, Hitchcock MG, et al. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg. 2000;26:671-678.
17. Johnson TM, Headington JT, Baker SR, et al. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. J Am Acad Dermatol. 1997;37:758-764.
18. Shriner DL, McCoy DK, Goldberg DJ, et al. Mohs micrographic surgery. J Am Acad Dermatol. 1998;39:79-97.
19. Nield DV, Saad MN, Khoo CT, et al. Tumour thickness in malignant melanoma: the limitations of frozen section. Br J Plast Surg. 1988;41:403-407.
20. Zitelli JA, Moy RL, Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol. 1991;24:102-106.
21. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997;37:236-245.
22. Gross EA, Andersen WK, Rogers GS. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol. 1999;135:15-17.
23. Zalla MJ, Lim KK, Dicaudo DJ, et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg. 2000;26:771-784.
24. Cohen LM. Management of lentigo maligna and lentigo maligna melanoma with tangential paraffin-embedded sections [letter]. J Am Acad Dermatol. 1994;31:691-692.
25. Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma: a follow-up study. Dermatol Surg. 1998;24: 673-677.
26. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-527.
27. Kauvar ANB, Geronemus R. Treatment of lentigo maligna with the Q-switched ruby laser [abstract]. Lasers Surg Med. 1995;(suppl 7):48.
28. Lee PK, Rosenburg CN, Tsao H, et al. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998;38:314-317.
29. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
30. Dorr RT. Interferon-alpha in malignant and viral diseases: a review. Drugs. 1993;45:177-211.
31. Cornejo P, Vanaclocha F, Polimon I, et al. Intralesional interferon treatment of lentigo maligna. Arch Dermatol. 2000; 136:428-430.
32. Ahmed I, Berth-Jones J. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol. 2000;143:843-845.